Role of Adjuvant Treatment in Esophageal Cancer With Incidental Pathologic Node Positivity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Role of Adjuvant Treatment in Esophageal Cancer With Incidental Pathologic Node Positivity

Published:2017-07 Issue:1 Volume:104 Page:267-274
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Gao Sarah J.,Park Henry S.,Corso Christopher D.,Rutter Charles E.,Kim Anthony W.,Johung Kimberly L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference30 articles.

1. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901;Mariette;J Clin Oncol,2014

2. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

3. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial;Shapiro;Lancet Oncol,2015

4. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781;Tepper;J Clin Oncol,2008

5. Association between clinically staged node-negative esophageal adenocarcinoma and overall survival benefit from neoadjuvant chemoradiation;Gabriel;JAMA Surg,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal lymph node yield in oesophagectomy for oesophageal cancer: a nationwide population-based study;European Journal of Cardio-Thoracic Surgery;2024-03-01

2. A multicenter randomized, controlled clinical trial of adjuvant sintilimab for esophageal squamous cell carcinoma;Future Oncology;2023-08

3. Association of survival with adjuvant radiotherapy for pN0 esophageal cancer;Aging;2023-04-25

4. Standard Lymphadenectomy for Esophageal and Lung Cancer: Variability in the Number of Examined Lymph Nodes Among Pathologists and Its Survival Implication;Annals of Surgical Oncology;2022-11-25

5. Survival benefit of perioperative chemotherapy for T1–3N0M0 stage esophageal cancer: a SEER database analysis;Journal of Thoracic Disease;2021-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3